A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan
Yoshinori Takeuchi, Masao Iwagami, Sachiko Ono, Nobuaki Michihata, Kohei Uemura, Hideo Yasunaga
Topics & Concepts
MedicineVaccinationPoisson regressionCohortAdverse effectPulmonary embolismInternal medicineEmergency medicinePediatricsImmunologyEnvironmental healthPopulationSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisCOVID-19 Impact on Reproduction